VEGF-mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation

Developmental Biology

Volumn 373, Issue 1, 2013, Pages 163-175

  Gentile, Carmine ^a   Muise Helmericks, Robin C ^a   Drake, Christopher J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angioblasts; Embryo; Endothelial nitric oxide synthase; Proliferation; Vasculogenesis; VEGF

Indexed keywords

AKT1 PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

AMNION FLUID; ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL LINEAGE; CELL PROLIFERATION; CELL SUBPOPULATION; EMBRYO; EMBRYO CELL; EMBRYONIC ENDOTHELIAL CELL; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FETUS MEMBRANE; HEMANGIOBLAST; MOUSE; MOUSE EMBRYO; MOUSE STRAIN; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84870056476     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.10.020     Document Type: Article

References (50)

1. Argraves K.M., Wilkerson B.A., Argraves W.S., Fleming P.A., Obeid L.M., Drake C.J. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J. Biol. Chem. 2004, 279:50580-50590.
2. Argraves W.S., Larue A.C., Fleming P.A., Drake C.J. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev. Dyn. 2002, 225:298-304.
3. Baldwin H.S., Shen H.M., Yan H.C., DeLisser H.M., Chung A., Mickanin C., Trask T., Kirschbaum N.E., Newman P.J., Albelda S.M. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 1994, 120:2539-2553.
4. Balligand J.L., Feron O., Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol. Rev. 2009, 89:481-534.
5. Bautch V.L., Redick S.D., Scalia A., Harmaty M., Carmeliet P., Rapoport R. Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. Blood 2000, 95:1979-1987.
6. Braam B., de Roos R., Dijk A., Boer P., Post J.A., Kemmeren P.P., Holstege F.C., Bluysen H.A., Koomans H.A. Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1977-H1986.
7. Chen H.H., Wang D.L. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol. Pharmacol. 2004, 65:1130-1140.
8. Crosby C.V., Fleming P.A., Argraves W.S., Corada M., Zanetta L., Dejana E., Drake C.J. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2005, 105:2771-2776.
9. Dai X., Faber J.E. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ. Res. 2010, 106:1870-1881.
10. Drake C.J., Brandt S.J., Trusk T.C., Little C.D. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol. 1997, 192:17-30.
11. Drake C.J., Fleming P.A. Vasculogenesis in the day 6.5-9.5 mouse embryo. Blood 2000, 95:1671-1679.
12. Dudzinski D.M., Michel T. Life history of eNOS: partners and pathways. Cardiovasc. Res. 2007, 75:247-260.
13. Eglen R.M. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton. Autacoid Pharmacol. 2006, 26:219-233.
14. Esner M., Meilhac S.M., Relaix F., Nicolas J.F., Cossu G., Buckingham M.E. Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome. Development 2006, 133:737-749.
15. Fontana J., Fulton D., Chen Y., Fairchild T.A., McCabe T.J., Fujita N., Tsuruo T., Sessa W.C. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 2002, 90:866-873.
16. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2011, 33:829-837.
17. Garcia-Cardena G., Folkman J. Is there a role for nitric oxide in tumor angiogenesis?. J. Natl. Cancer Inst. 1998, 90:560-561.
18. Gelinas D.S., Bernatchez P.N., Rollin S., Bazan N.G., Sirois M.G. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br. J. Pharmacol. 2002, 137:1021-1030.
19. Giles P.B., Candy C.L., Fleming P.A., Owens R.W., Argraves W.S., Drake C.J. VEGF directs newly gastrulated mesoderm to the endothelial lineage. Dev. Biol. 2005, 279:169-178.
20. Guthrie S.M., Curtis L.M., Mames R.N., Simon G.G., Grant M.B., Scott E.W. The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 2005, 105:1916-1922.
21. Hsieh T.C., Lu X., Guo J., Wu J.M. Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol. Int. J. Mol. Med. 2010, 26:743-749.
22. Illi B., Dello Russo C., Colussi C., Rosati J., Pallaoro M., Spallotta F., Rotili D., Valente S., Ragone G., Martelli F., Biglioli P., Steinkuhler C., Gallinari P., Mai A., Capogrossi M.C., Gaetano C. Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ. Res. 2008, 102:51-58.
23. Iwakiri Y. S-nitrosylation of proteins: a new insight into endothelial cell function regulated by eNOS-derived NO. Nitric Oxide 2011, 25:95-101.
24. Kallianpur A.R., Jordan J.E., Brandt S.J. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 1994, 83:1200-1208.
25. Kolluru G.K., Siamwala J.H., Chatterjee S. eNOS phosphorylation in health and disease. Biochimie 2010, 92:1186-1198.
26. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P., Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 1992, 118:1511-1522.
27. LaRue A.C., Argraves W.S., Zile M.H., Drake C.J. A critical role for retinol in the generation/differentiation of angioblasts required for embryonic blood vessel formation. Dev. Dyn. 2004, 230:666-674.
28. LaRue A.C., Mironov V.A., Argraves W.S., Czirok A., Fleming P.A., Drake C.J. Patterning of embryonic blood vessels. Dev. Dyn. 2003, 228:21-29.
29. Lin M.I., Fulton D., Babbitt R., Fleming I., Busse R., Pritchard K.A., Sessa W.C. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J. Biol. Chem. 2003, 278:44719-44726.
30. Lin M.I., Sessa W.C. Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: more than a FLeeTing moment. Circ. Res. 2006, 99:666-668.
31. Mao C., Tili E.G., Dose M., Haks M.C., Bear S.E., Maroulakou I., Horie K., Gaitanaris G.A., Fidanza V., Ludwig T., Wiest D.L., Gounari F., Tsichlis P.N. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J. Immunol. 2007, 178:5443-5453.
32. Michel T., Feron O. Nitric oxide synthases: which, where, how, and why?. J. Clin. Invest. 1997, 100:2146-2152.
33. Mu J., Adamson S.L. Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1421-H1428.
34. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 1998, 101:2567-2578.
35. Nath A.K., Enciso J., Kuniyasu M., Hao X.Y., Madri J.A., Pinter E. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 2004, 131:2485-2496.
36. Oliveira C.J., Curcio M.F., Moraes M.S., Tsujita M., Travassos L.R., Stern A., Monteiro H.P. The low molecular weight S-nitrosothiol, S-nitroso-N-acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide 2008, 18:241-255.
37. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 1997, 100:3131-3139.
38. Paul D.M., Vilas S.P., Kumar J.M. A flow-cytometry assisted segregation of responding and non-responding population of endothelial cells for enhanced detection of intracellular nitric oxide production. Nitric Oxide 2011, 25:31-40.
39. Polytarchou C., Papadimitriou E. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur. J. Pharmacol. 2005, 510:31-38.
40. Schleicher M., Yu J., Murata T., Derakhshan B., Atochin D., Qian L., Kashiwagi S., Di Lorenzo A., Harrison K.D., Huang P.L., Sessa W.C. The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2009, 2:ra41.
41. Sessa W.C. eNOS at a glance. J. Cell Sci. 2004, 117:2427-2429.
42. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
43. Spallotta F., Rosati J., Straino S., Nanni S., Grasselli A., Ambrosino V., Rotili D., Valente S., Farsetti A., Mai A., Capogrossi M.C., Gaetano C., Illi B. Nitric oxide determines mesodermic differentiation of mouse embryonic stem cells by activating class IIa histone deacetylases: potential therapeutic implications in a mouse model of hindlimb ischemia. Stem Cells 2010, 28:431-442.
44. Taylor S.M., Nevis K.R., Park H.L., Rogers G.C., Rogers S.L., Cook J.G., Bautch V.L. Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood 2010, 116:3108-3117.
45. Vittet D., Buchou T., Schweitzer A., Dejana E., Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc. Natl. Acad. Sci. USA 1997, 94:6273-6278.
46. Wasteson P., Johansson B.R., Jukkola T., Breuer S., Akyurek L.M., Partanen J., Lindahl P. Developmental origin of smooth muscle cells in the descending aorta in mice. Development 2008, 135:1823-1832.
47. Wood H.B., May G., Healy L., Enver T., Morriss-Kay G.M. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 1997, 90:2300-2311.
48. Wyatt A.W., Steinert J.R., Mann G.E. Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem. Soc. Symp. 2004, 143-156.
49. Young P.E., Baumhueter S., Lasky L.A. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 1995, 85:96-105.
50. Yue X., Tomanek R.J. Effects of VEGF(165) and VEGF(121) on vasculogenesis and angiogenesis in cultured embryonic quail hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2240-H2247.